Viewing Study NCT06451094



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06451094
Status: COMPLETED
Last Update Posted: 2024-06-11
First Post: 2024-06-03

Brief Title: Effectiveness Transfer Energy Capacitive and Resistive Therapy in Patients With Carpal Tunnel Syndrome
Sponsor: Ankara City Hospital Bilkent
Organization: Ankara City Hospital Bilkent

Study Overview

Official Title: Comparison of the Effectiveness of Ultrasound and Transfer Energy Capacitive and Resistive TECAR Therapy in Patients With Carpal Tunnel Syndrome
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Objective The aim of this study was to evaluate the effect of Transfer Energy Capacitive and Resistive TECAR therapy on pain symptom severity and function in patients diagnosed with carpal tunnel syndrome CTS based on clinical and electromyography EMG findings and to compare it with ultrasound therapy US

Methods A total of 42 patients aged between 18 and 65 years were randomly divided into two groups group 1 US therapy 5 minutes intermittently for 2 weeks 5 times a week for a total of 10 sessions group 2 TECAR therapy 5 min capacitive CAP and 10 min resistive RES 3 days a week for 2 weeks for a total of 6 sessions Both groups received paraffin therapy and wrist orthosis All Patients were evaluated using the Visual Analog Scale VAS for pain and paresthesia levels the Boston Carpal Tunnel Questionnaire BCTQ for symptom severity and functional levels Additionally median nerve CSA was measured by ultrasound at the baseline post-treatment first and third months
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None